Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

The interaction between dopamine transporter function, gender differences, and possible laterality in depression.

Hsiao MC, Lin KJ, Liu CY, Schatz DB.

Psychiatry Res. 2013 Jan 30;211(1):72-7. doi: 10.1016/j.pscychresns.2012.06.004. Epub 2012 Oct 1.

PMID:
23036826
2.

Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study.

Argyelán M, Szabó Z, Kanyó B, Tanács A, Kovács Z, Janka Z, Pávics L.

J Affect Disord. 2005 Dec;89(1-3):115-23. Epub 2005 Oct 5.

PMID:
16213028
3.

Bupropion occupancy of the dopamine transporter is low during clinical treatment.

Meyer JH, Goulding VS, Wilson AA, Hussey D, Christensen BK, Houle S.

Psychopharmacology (Berl). 2002 Aug;163(1):102-5. Epub 2002 Jul 13.

PMID:
12185406
4.

Greater striatal dopamine transporter density may be associated with major depressive episode.

Amsterdam JD, Newberg AB, Soeller I, Shults J.

J Affect Disord. 2012 Dec 10;141(2-3):425-31. doi: 10.1016/j.jad.2012.03.007. Epub 2012 Apr 4.

5.

A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls.

Amsterdam JD, Newberg AB.

Neuropsychobiology. 2007;55(3-4):167-70. Epub 2007 Jul 26.

PMID:
17657170
6.

Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging.

Brunswick DJ, Amsterdam JD, Mozley PD, Newberg A.

Am J Psychiatry. 2003 Oct;160(10):1836-41. Erratum in: Am J Psychiatry. 2004 Feb;161(2):384.

PMID:
14514499
7.

Dopamine transporter density may be associated with the depressed affect in healthy subjects.

Newberg A, Amsterdam J, Shults J.

Nucl Med Commun. 2007 Jan;28(1):3-6.

PMID:
17159542
8.

Dopamine transporter binding in social anxiety disorder: the effect of treatment with escitalopram.

Warwick JM, Carey PD, Cassimjee N, Lochner C, Hemmings S, Moolman-Smook H, Beetge E, Dupont P, Stein DJ.

Metab Brain Dis. 2012 Jun;27(2):151-8. doi: 10.1007/s11011-012-9280-3. Epub 2012 Feb 16.

PMID:
22350963
9.

Changes of dopamine transporter availability in depressed patients with and without anhedonia: a 123I-N-ω-fluoropropyl-carbomethoxy-3β- (4-Iodophenyl)tropane SPECT study.

Camardese G, De Risio L, Di Nicola M, Pucci L, Cocciolillo F, Bria P, Giordano A, Janiri L, Di Giuda D.

Neuropsychobiology. 2014;70(4):235-43. doi: 10.1159/000368117. Epub 2015 Jan 20.

PMID:
25613182
10.

[Change of dopamine transporter activity (DAT) during the action of bupropion (in depression)].

Szabó Z, Argyelán M, Kanyó B, Pávics L, Janka Z.

Neuropsychopharmacol Hung. 2004 Jun;6(2):79-81. Hungarian.

PMID:
15787205
11.

Higher dopamine transporter density in Parkinson's disease patients with depression.

Felicio AC, Moriyama TS, Godeiro-Junior C, Shih MC, Hoexter MQ, Borges V, Silva SM, Amaro-Junior E, Andrade LA, Ferraz HB, Bressan RA.

Psychopharmacology (Berl). 2010 Jul;211(1):27-31. doi: 10.1007/s00213-010-1867-y. Epub 2010 May 22.

PMID:
20495790
12.

Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression.

Little JT, Ketter TA, Kimbrell TA, Dunn RT, Benson BE, Willis MW, Luckenbaugh DA, Post RM.

Biol Psychiatry. 2005 Feb 1;57(3):220-8.

PMID:
15691522
13.

Evaluation of Tourette's syndrome by (99m)Tc-TRODAT-1 SPECT/CT imaging.

Liu H, Dong F, Meng Z, Zhang B, Tan J, Wang Y.

Ann Nucl Med. 2010 Aug;24(7):515-21. doi: 10.1007/s12149-010-0389-3. Epub 2010 Jun 11.

PMID:
20544324
14.

Higher striatal dopamine transporter density in PTSD: an in vivo SPECT study with [(99m)Tc]TRODAT-1.

Hoexter MQ, Fadel G, Felício AC, Calzavara MB, Batista IR, Reis MA, Shih MC, Pitman RK, Andreoli SB, Mello MF, Mari JJ, Bressan RA.

Psychopharmacology (Berl). 2012 Nov;224(2):337-45. doi: 10.1007/s00213-012-2755-4. Epub 2012 Jun 15.

PMID:
22700036
15.

Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.

Szobot CM, Shih MC, Schaefer T, Júnior N, Hoexter MQ, Fu YK, Pechansky F, Bressan RA, Rohde LA.

Neuroimage. 2008 Apr 15;40(3):1195-201. doi: 10.1016/j.neuroimage.2007.12.050. Epub 2008 Jan 10.

PMID:
18282769
16.

No changes in striatal dopamine transporter in antidepressant-treated patients with major depression.

Wu CK, Chin Chen K, See Chen P, Chiu NT, Yeh TL, Lee IH, Yang YK.

Int Clin Psychopharmacol. 2013 May;28(3):141-4. doi: 10.1097/YIC.0b013e32835ebcd7.

PMID:
23524636
17.

Dopamine transporter availability in heroin-dependent subjects and controls: longitudinal changes during abstinence and the effects of Jitai tablets treatment.

Liu Y, Han M, Liu X, Deng Y, Li Y, Yuan J, Lv R, Wang Y, Zhang G, Gao J.

Psychopharmacology (Berl). 2013 Nov;230(2):235-44. doi: 10.1007/s00213-013-3148-z. Epub 2013 May 29.

PMID:
23715641
18.

Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.

Weintraub D, Newberg AB, Cary MS, Siderowf AD, Moberg PJ, Kleiner-Fisman G, Duda JE, Stern MB, Mozley D, Katz IR.

J Nucl Med. 2005 Feb;46(2):227-32.

19.

Reproducibility of brain dopamine transporter binding with Tc-99m TRODAT-1 SPECT in healthy young men.

Yeh CB, Chou YH, Cheng CY, Lee MS, Wang JJ, Lee CH, Shiue CY, Su TP, Huang WS.

Psychiatry Res. 2012 Mar 31;201(3):222-5. doi: 10.1016/j.pscychresns.2011.07.004. Epub 2012 Apr 30.

PMID:
22551783
20.

Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1.

Hsiao MC, Lin KJ, Liu CY, Tzen KY, Yen TC.

Schizophr Res. 2003 Dec 1;65(1):39-46.

PMID:
14623373

Supplemental Content

Support Center